Open access
1,328
Views
34
CrossRef citations to date
0
Altmetric
Clinical Research
Assessing the benefit:risk ratio of a drug - randomized and naturalistic evidence
Evaluación de la relación riesgo-beneficio de un fármaco mediante la evidencia randomizada y naturalística
Évaluation du bénéfice-risque d'un médicament: données randomisées et naturalistiques
François Curtina GeNeuro SA, Plan les Ouates, SwitzerlandCorrespondence[email protected]
& Pierre Schulzb Clinical Psychopharmacology Unit, Geneva University Hospital, Geneva Medical Faculty, Switzerland
Pages 183-190
|
Published online: 01 Apr 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.